Key facts
- Harrison-AI’s last known valuation is $314.7M (May 2024).
- It has raised $271.3M; the latest was Later Stage VC ($111.8M) in Feb 2025.
- Notable investors include Blackbird Ventures, Horizons Ventures, Skip Capital, Alpha JWC Ventures, Foggy Valley Aotearoa — 15 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 15 names
- ·Watchlist + deal alerts for Harrison-AI
- ·The full record, as it builds
Funding rounds
No funding rounds for Harrison-AI are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Harrison-AI
Developer of an artificial intelligence-based healthcare platform designed to commercialize efficient and affordable healthcare products and services. The company's platform empowers physicians and healthcare providers with customized AI-enabled tools that integrate into existing clinical workflows, enabling medical institutions to improve patient outcomes.
- Sector
- Healthcare
- HQ
- Sydney, Australia
- Founded
- 2018
- Employees
- 200
- Website
- harrison.ai/
- Ownership
- Privately Held (backing)
Harrison-AI doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Harrison-AI shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Harrison-AI in its N-PORT filings yet. We sweep new filings monthly.